Tang Xiaolong, Zhang Mengjun, He Qingsi, Sun Guorui, Wang Chao, Gao Peng, Qu Hui
Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Department of General Surgery, Lanling People's Hospital, Linyi, China.
Front Oncol. 2020 Sep 3;10:1743. doi: 10.3389/fonc.2020.01743. eCollection 2020.
Histological differentiated/undifferentiated mixed-type adenocarcinomas are frequently found in patients with early gastric cancer (EGC). Yet it is unclear whether these mixed-type adenocarcinomas can be treated by endoscopic resection (ER) in EGC patients.
To evaluate the lymph node metastasis (LNM) rate and long-term outcomes in mixed-type EGC patients and assess the feasibility of ER in these patients.
Clinicopathological features, risk factors of LNM, and overall survival (OS) and progression-free survival (PFS) rates of EGC patients were analyzed according to different histological types.
Patients with mixed-type EGC had higher LNM rates than patients with non-mixed-type EGC (11.4 vs. 6.2%, = 0.044). In the multivariate analysis, larger tumor diameter, presence of an ulcer, submucosal invasion, histological undifferentiated type, histological mixed type, and lymphovascular invasion resulted as independent risk factors for LNM in EGC patients (all < 0.05). The LNM rate in mixed-type patients who met the Japanese ER criteria was 3.3%, including fulfilling the absolute criteria 0%. The 5-year OS and PFS rates in mixed-type patients were 94.59 and 91.47%, respectively. There was no statistical significance in the OS ( = 0.870) and PFS ( = 0.705) between mixed-type and non-mixed-type EGC patients fulfilling the Japanese ER criteria.
Histological differentiated/undifferentiated mixed type in EGC patients meeting the Japanese absolute criteria for ER are associated with low risk of LNM and favorable prognosis, and thus, it should not be considered as a non-curative factor for ER.
组织学上分化型/未分化型混合型腺癌在早期胃癌(EGC)患者中较为常见。然而,目前尚不清楚这些混合型腺癌在EGC患者中是否可通过内镜切除(ER)进行治疗。
评估混合型EGC患者的淋巴结转移(LNM)率和长期预后,并评估ER在这些患者中的可行性。
根据不同组织学类型分析EGC患者的临床病理特征、LNM的危险因素以及总生存期(OS)和无进展生存期(PFS)率。
混合型EGC患者的LNM率高于非混合型EGC患者(11.4%对6.2%,P = 0.044)。在多因素分析中,肿瘤直径较大、存在溃疡、黏膜下浸润、组织学未分化型、组织学混合型和淋巴管浸润是EGC患者LNM的独立危险因素(均P < 0.05)。符合日本ER标准的混合型患者的LNM率为3.3%,其中符合绝对标准的为0%。混合型患者的5年OS率和PFS率分别为94.59%和91.47%。符合日本ER标准的混合型和非混合型EGC患者在OS(P = 0.870)和PFS(P = 0.705)方面无统计学差异。
符合日本ER绝对标准的EGC患者中的组织学分化型/未分化型混合型与LNM风险低和预后良好相关,因此,不应将其视为ER的非治愈因素。